Nothing said here yet.
to join the conversation.
| GALLAGHER JOHN RChief Operating Officer | Sell | 431 | $12.6K | Wed, Oct 28 |
| Tooth MargaretCEO | Sell | 1,000 | $25.8K | Fri, Oct 9 |
| GALLAGHER JOHN RChief Operating Officer | Sell | 431 | $9.9K | Mon, Sep 28 |
| Tooth MargaretCEO | Sell | 1,000 | $25.0K | Fri, Sep 11 |
| GALLAGHER JOHN RChief Operating Officer | Sell | 3,604 | $107.0K | Fri, Aug 28 |
| Qureshi FawwadChief Financial Officer | Sell | 6,111 | $183.4K | Wed, Aug 26 |
| Tooth MargaretCEO | Sell | 491 | $15.6K | Tue, Aug 25 |
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Trupanion trades at a premium after a 36.5% YTD drop, as slower pet growth and rising claims costs weigh on margins despite expansion plans.
Since March 2026, Trupanion has been in a holding pattern, posting a small loss of 4.5% while floating around $25.08. The stock also fell short of the S&P 500’s 16.4% gain during that period.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Trupanion (NASDAQ:TRUP) and its peers.
Trupanion, North America’s leading pet insurer, today announced the launch of its annual truFame contest.
Trupanion Stock Performance Snapshot Trupanion (TRUP) has drawn investor interest after recent trading left the stock at a last close of $28.79.
Shares of pet insurance provider Trupanion (NASDAQ:TRUP) fell 5.8% in the afternoon session after Piper Sandler downgraded the pet insurance provider's stock to Neutral from Overweight and lowered its price target to $32 from $45.